Opinions and Legal Insights

Latham & Watkins Advises Underwriters in Mirati Therapeutics, Inc.’s US$800 Million Public Offering of Common Stock

Mirati Therapeutics, Inc., a San Diego-based late-stage biotechnology company, has announced the pricing of an underwritten public offering of 4,335,397 shares of its common stock at a price to the […]

The post Latham & Watkins Advises Underwriters in Mirati Therapeutics, Inc.’s US$800 Million Public Offering of Common Stock appeared first on Legal Desire.